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ABSTRACT
Background: High-throughput sequencing is now regularly used for studies of the transcrip-
tome (RNA-seq), particularly for comparisons among experimental conditions. For the time being,
a limited number of biological replicates are typically considered in such experiments, leading to
low detection power for differential expression. As their cost continues to decrease, it is likely that
additional follow-up studies will be conducted to re-address the same biological question.
Results: We demonstrate how p-value combination techniques previously used for microarray
meta-analyses can be used for the differential analysis of RNA-seq data from multiple related
studies. These techniques are compared to a negative binomial generalized linear model (GLM)
including a fixed study effect on simulated data and real data on human melanoma cell lines. The
GLM with fixed study effect performed well for low inter-study variation and small numbers of
studies, but was outperformed by the meta-analysis methods for moderate to large inter-study
variability and larger numbers of studies.
Conclusions: The p-value combination techniques illustrated here are a valuable tool to perform
differential meta-analyses of RNA-seq data by appropriately accounting for biological and technical
variability within studies as well as additional study-specific effects. An R package metaRNASeq is
available on the R Forge.
Keywords: meta-analysis, RNA-seq, differential expression, p-value combination
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1 Background
Studies of gene expression have come to rely increasingly on the use of high-throughput sequencing
(HTS) techniques to directly sequence libraries of reads (i.e., nucleotide sequences) arising from the
transcriptome (RNA-seq), yielding counts of the number of reads arising from each gene. Although
the costs of HTS experiments continue to decrease, for the time being RNA-seq experiments are
typically performed on very few biological replicates, and therefore analyses to detect differential
expression between two experimental conditions tend to lack detection power. However, as costs
continue to decrease, it is likely that additional follow-up experiments will be conducted to re-
address some biological questions, suggesting a future need for methods able to jointly analyze
data from multiple studies. In particular, such methods must be able to appropriately account
for the biological and technical variability among samples within a given study as well as for the
additional variability due to study-specific effects. Such inter-study variability may arise due to
technical differences among studies (e.g., sample preparation, library protocols, batch effects) as
well as additional biological variability.
In recent years, several methods have been proposed to analyze microarray data arising from
multiple independent but related studies; these meta-analysis techniques have the advantage of in-
creasing the available sample size by integrating related datasets, subsequently increasing the power
to detect differential expression. Such meta-analyses include, for example, methods to combine p-
values [14], estimate and combine effect sizes [6], and rank genes within each study [4]; see [10]
and [9] for a review and comparison of such methods. In particular, [14] showed that the inverse
normal p-value combination technique outperformed effect size combination methods or moderated
t-tests [18] obtained from a linear model with a fixed study effect on several criteria, including
sensitivity, area under the Receiver Operating Characteristic (ROC) curve, and gene ranking.
In many cases the meta-analysis techniques previously used for microarray data are not directly
applicable for RNA-seq data. In particular, differential analyses of microarray data, whether for one
or multiple studies, typically make use of a standard or moderated t-test [11, 18], as such data are
continuous and may be roughly approximated by a Gaussian distribution after log-transformation.
On the other hand, the growing body of work concerning the differential analysis of RNA-seq data
has primarily focused on the use of overdispersed Poisson [2] or negative binomial models [1, 17]
in order to account for their highly heterogeneous and discrete nature. Under these models, the
calculation and interpretation of effect sizes is not straightforward. [12] recently proposed an effect
size combination method for Poisson-distributed data, based on an Anscombe transformation, but
this method is not well-adapted to RNA-seq data due to the presence of over-dispersion among
biological replicates as well as zero-inflation. To our knowledge, no other transformation has been
proposed to obtain effect sizes for over-dispersed Poisson or negative binomial data.
In this paper, we consider several methods for the integrated analysis of RNA-seq data arising
from multiple related studies, including two p-value combination methods as well as a model fitted
over the full data with a fixed study effect. We first demonstrate how the inverse normal and
Fisher p-value combination methods can be adapted to the differential meta-analysis of RNA-seq
data. Then we compare these two methods to the results of independent per-study analyses and a
negative binomial generalized linear model (GLM) with a fixed study effect as implemented in the
DESeq Bioconductor package [1]. All methods are compared on real data from two related studies
on human melanoma cell lines, as well as in an extensive set of simulations varying the inter-study
variability, number of studies, and biological replicates per study.
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Finally, we note that our focus is on RNA-seq data arising from two or more studies in which all
experimental conditions under consideration are included in every study (with potentially different
numbers of biological replicates); differential analyses among conditions that are not studied in the
same experiment are typically limited, or even compromised, due to the confounding of condition
and study effects.
2 Methods
Let ygcrs be the observed count for gene g (g = 1, . . . , G), condition c (c = 1, 2), biological replicate
r (r = 1, . . . Rcs), and study s (s = 1, . . . , S). Note that the number of biological replicates Rcs may
vary between conditions and among studies. Let µgcs be the mean expression level for gene g in
condition c and study s. For an integrated differential analysis of gene expression across all studies,
two approaches can be envisaged: the combination of p-values from per-study differential analyses,
and a global differential analysis. We illustrate both using the default methods and parameters of
the DESeq (v1.10.1) analysis pipeline [1], although other popular methods, e.g., edgeR [17], could
also be used.
2.1 P -value combination from independent analyses
For the differential analysis of gene expression within a given study s, we assume that gene counts
ygcrs follow a negative binomial distribution parameterized by its mean `crsµgcs and dispersion
αgs, where `crs is a normalization factor to correct for differences in library size. A comparison of
different methods to estimate `crs may be found in [7]. We are interested in testing the per-gene
null hypothesis
H0,gs : µg1s = µg2s vs H1,gs : µg1s 6= µg2s. (1)
After obtaining per-gene mean and dispersion parameter estimates, a parametric gamma regression
is used to obtain fitted dispersion estimates by pooling information from genes with similar expres-
sion strengths. Raw per-gene p-values pgs are subsequently computed using a conditioned test
analogous to Fisher’s exact test. Additional details may be found in [1] and the DESeq package vi-
gnette. Once these vectors of raw p-values have been obtained, we consider two possible approaches
to combine them across studies: the inverse normal and the Fisher combination methods. We note
that both of these approaches assume that under the null hypothesis, each vector of p-values is
assumed to be uniformly distributed.
2.1.1 Inverse normal method
For each gene g, we define
Ng =
S∑
s=1
wsΦ
−1(1− pgs) (2)
where pgs corresponds to the raw p-value obtained for gene g in a differential analysis for study
s, Φ the cumulative distribution function of the standard normal distribution, and ws a set of
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weights [13]. We propose here to define the study-specific weights ws as in [15]:
ws =
√ ∑
cRcs∑
`
∑
cRc`
,
where
∑
cRcs is the total number of biological replicates in study s. This allows studies with large
numbers of biological replicates to be attributed a larger weight than smaller studies. We note that
other weights may also be defined by the user depending on the quality of the data in each study,
if this information is available.
Under the null hypothesis, the test statistic Ng in Equation (2) follows a N (0, 1) distribution.
A unilateral test on the right-hand tail of the distribution may then be performed, and classical
procedures for the correction of multiple testing such as [3] may subsequently be applied to the
obtained p-values to control the false discovery rate at a desired level α.
2.1.2 Fisher combination method
For the Fisher combination method [8], the test statistic for each gene g may be defined as
Fg = −2
S∑
s=1
ln(pgs), (3)
where as before pgs corresponds to the raw p-value obtained for gene g in a differential analysis for
study s. Under the null hypothesis, the test statistic Fg in Equation (3) follows a χ
2 distribution
with 2S degrees of freedom. As with the inverse normal p-value combination method, classical
procedures for the correction of multiple testing such as [3] may be applied to the obtained p-values
to control the false discovery rate at a desired level α.
2.1.3 Additional considerations for p-value combination
We note that the implementation of the previously described p-value combination techniques re-
quires two additional considerations to be taken into account.
First, a crucial underlying assumption for the statistics defined in Equations (2) and (3) is
that p-values for all genes arising from the per-study differential analyses are uniformly distributed
under the null hypothesis H0,gs defined in Equation (1). This assumption is, however, not always
satisfied for RNA-seq data; in particular, a peak is often observed for p-values close to 1 due to
the discretization of p-values for very low counts. To circumvent this first difficulty, we propose to
filter the weakly expressed genes in each study using the HTSFilter Bioconductor package [16], as
described in the Supplementary Materials. We note that in so doing, it is possible for a gene to
be filtered from one study and not from another. As will be seen in the following, this approach
appears to effectively filter those genes contributing to a peak of large p-values, resulting in p-values
that appear to be roughly uniformly distributed under the null hypothesis.
Second, for the two p-value combination methods described above, unlike microarray data,
under- and over-expressed genes are analyzed together for RNA-seq data. As such, some care must
be taken to identify genes exhibiting conflicting expression patterns (i.e., under-expression when
comparing one condition to another in one study, and over-expression for the same comparison in
another study). We suggest that genes exhibiting differential expression conflicts among studies be
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identified post hoc, and removed from the list of differentially expressed genes; this step to remove
genes with conflicting differential expression from the final list of differentially expressed genes may
be performed automatically within the associated R package metaRNASeq.
2.2 Global differential analysis
For a global analysis of RNA-seq data arising from multiple studies, we assume that gene counts
ygcrs follow a negative binomial distribution parameterized by the mean `crsµgcs and dispersion
αg, where `crs is the library size normalization factor. We are now interested in testing the global
per-gene null hypothesis
H0,g : µg1 = µg2 vs H1,g : µg1 6= µg2.
Per-gene mean and fitted dispersion estimates are obtained as before. In order to estimate a possible
effect due to study, a full and reduced model are fitted for each gene using negative binomial
generalized linear models (GLM); the full model regresses gene expression on the experimental
condition and study, while the reduced model regresses gene expression only on the study. The
two models are compared using a χ2 likelihood ratio test to determine whether including the
experimental condition significantly improves the model fit. Note that for the global differential
analysis we use the HTSFilter Bioconductor package [16] to filter the full set of data across studies,
resulting in a vector of raw filtered per-gene p-values that may be corrected for multiple testing
using classical procedures [3] to control the false discovery rate at a desired level α. Additional
details may be found in the DESeq package vignette.
3 Results and Discussion
3.1 Application to real data
3.1.1 Presentation of the data
The negative binomial GLM and p-value combination methods were applied to a pair of real RNA-
seq studies performed to compare two human melanoma cell lines [19]. Each study compares gene
expression in a melanoma cell line expressing the Microphtalmia Transcription Factor (MiTF) to
one in which small interfering RNAs (siRNAs) were used to repress MiTF, with three biological
replicates per cell line in the first (hereafter referred to as Study A) and two per cell line in the
second (Study B). The raw read counts and phenotype tables for Study A are available in the
Supplementary Materials of [7], and the data from Study B from [19].
The characteristics of the data from these two studies are summarized in Supplementary Table
2. In particular, we note that the data from Study A tend to have larger total library sizes and a
smaller number of unique reads than those from Study B; in addition, Study A appears to exhibit
larger overall per-gene variability than does Study B (Supplementary Figure 8). These two points
indicate that in this pair of studies, a considerable amount of inter-study variability appears to be
present (Supplementary Figure 9).
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3.1.2 Results
After performing individual differential analysis for each study using the negative binomial model
and exact test as described above, we obtained per-gene p-values for each study (Figure 1, his-
tograms in background). As previously stated, an important underlying assumption of the p-value
combination methods is that the p-values are uniformly distributed under the null hypothesis; we
note that this is not the case here, especially for the second study, due to a large peak of values close
to 1 resulting from the discretization of p-values. In order to remove the weakly expressed genes
contributing to this peak in each study, we filtered the data from each study as proposed in [16],
resulting in a distribution of raw p-values from each study that appears to satisfy the uniformity
assumption under the null hypothesis (Figure 1, histograms in foreground).
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Figure 1: Histograms of raw p-values obtained from per-study differential analyses in the
real data: unfiltered (in grey) and filtered (in blue) using the method of [16]. Figure made
using the ggplot2 package [20].
The per-study filtered p-values were combined using the test statistics defined in Equations (2)
and (3), and the corresponding results were compared to those of the intersection of independent
per-study analyses and the global analysis using a negative binomial GLM with a fixed study
effect. We note that for the independent per-study differential analyses, a gene is declared to
be differentially expressed if identified in both studies with no differential expression conflict (see
Section 2.1.3).
The Venn diagram presented in Figure 2 compares the lists of differentially expressed genes
found for all methods considered. It may immediately be noticed that the independent per-study
analysis approach is very conservative, and both of the p-value combination approaches (Fisher
and inverse normal) considerably increase the detection power. In addition, a large number of
genes are found in common among the p-value combination methods and the global analysis (3578
compared to only 1583 from the intersection of individual studies). In order to determine whether
the genes uniquely identified by a particular method appear to be biologically pertinent, an In-
genuity Pathways Analysis (Ingenuity R© Systems, www.ingenuity.com) was performed to identify
functional annotation for the genes uniquely identified by the Fisher p-value combination method
with respect to the global analysis, and vice versa. We note that the sets of genes uniquely iden-
tified by the Fisher method or the global analysis (Supplementary Tables 2 and 3), as well as the
set of genes found in common (Supplementary Table 4), all appear to include genes of potential
interest related to cancer or melanoma, which was the main focus of this set of studies. As such,
for this pair of studies it appears that the union of genes identified by the two approaches may be
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Figure 2: Venn diagram presenting the results of the differential analysis for the real data
for the two meta-analysis methods (Fisher and inverse normal), the global analysis (DESeq
(study)), and the intersection of individual per-study analyses (Individual). Figure made
using the VennDiagrams package [5].
of biological interest; to further study the effect of number of studies and inter-study variability on
the performance of each method, we investigate an extensive set of simulated data in the following
section.
3.2 Simulation study
Data were simulated according to a negative binomial distribution,
Ygcrs ∼ NB(µgcs, φgs)
where µgcs and φgs represent the mean and dispersion, respectively, for gene g, condition c and
study s, and the mean-variance relationship is defined by
Var(Ygcrs) = µgcs +
µ2gcs
φgs
.
In order to incorporate inter-study variability, we consider the following situation for the mean
parameter µgcs:
log(µgcs) = wgc + εgcs, and εgcs ∼ N (0, σ2),
where wgc represents the overall mean for gene g in condition c, εgcs the variability around these
means due to a study effect, and σ2 the size of the inter-study variability. Note that as εgcs affects
µgcs through a log link, the value of exp(εgcs) has a multiplicative effect on the mean.
3.2.1 Parameters for simulations
To fix realistic values for the parameters {wgc, φgs, σ}, we first performed individual per-study
differential analyses by fitting a negative binomial model with the default methods and parameters
of the DESeq package (see Section 2.1) on the unfiltered human data presented in Section 3.1.
The per-study false discovery rate was subsequently controlled at the α = 0.05 level [3]. For the
genes identified as differentially expressed in both studies, wg1 and wg2 were fixed to be the values
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Table 1: Simulation settings, including the number of studies and the number of replicates
per condition in each study.
Setting # of studies Replicates/study
1 2 (2,3)
2 3 (2,2,3)
3 5 (2,2,3,3,3)
of the empirical means (after normalization for library size differences) for each condition across
studies. For the remaining genes, we set wg1 = wg2 = wg to be the overall empirical mean (after
normalization for library size differences) for gene g across both conditions and studies. Using the
gamma-family GLM fitted to the per-gene mean and dispersion parameter estimates for each study
(Supplementary Figure 8), we fixed the dispersion parameter φgs to be equal to the fitted values
φ−1gs = αˆ0s +
αˆ1s
wg
,
where αˆ0s and αˆ1s are the estimated coefficients from the gamma-family GLM for study s, and wg
is the overall empirical mean for gene g. For weakly expressed genes, it has been observed that
little overdispersion is present as biological variation is dominated by shot noise (i.e., the variation
inherent to a counting process); for genes with wg < 10, the dispersion parameter is therefore fixed
to be φgs = 10
10, which corresponds to nearly zero overdispersion (i.e., mean nearly equal to the
variance).
Finally, the parameter σ is chosen to represent a range of values for the amount of inter-study
variability. The observed human data exhibit a considerable amount of inter-study variability,
corresponding to a value of roughly σ = 0.5 (see Supplementary Materials, Figure 9). In the
following simulations, four values are considered for the parameter σ: {0, 0.15, 0.3, 0.5}, representing
zero, small, medium, and large inter-study variability, respectively. Finally, we note that for genes
simulated to be non-differentially expressed, we set εg1s = εg2s = εgs ∼ N (0, σ2).
The simulation settings used for the number of studies and number of replicates per condition in
each study are presented in Table 1 and were chosen to reflect the size of real RNA-seq experiments.
When more than two studies were simulated, the same simulation parameters were used as for the
first two, as determined from the real data. For simplicity, the same number of replicates was
simulated in each condition for all studies.
3.2.2 Methods and criteria for comparison
In addition to the intersection of independent per-study analyses (where genes were declared to be
differentially expressed if identified in more than half of the studies with no differential conflict),
the Fisher and inverse normal p-value combination techniques, and the global analysis with fixed
study effect, we also considered a global analysis with no study effect. For each simulation setting
and level of inter-study variability σ, 300 independent datasets were simulated, and the filtering
method of [16] was applied, either independently to each study (for the independent per-study
analyses and p-value combination techniques) or to the full set of data (for the global analysis).
For each method, performance was assessed using the sensitivity, false discovery rate (FDR) and
area under the receiver operating characteristic (ROC) curve (AUC). In addition, we also considered
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Figure 3: Receiver Operating Characteristic (ROC) curves, averaged over 300 datasets. Each
plot represents the results of a particular setting, with columns corresponding (from left to
right) to simulations including 2 studies, 3 studies, and 5 studies, and rows corresponding
(from top to bottom) to simulations with inter-study variability set to σ = 0.15 and σ = 0.50
(low inter-study variability to lareg inter-study variability). Within each plot: Fisher (red
lines), global analysis with no fixed study effect (DESeq (no study), blue lines), and global
analysis with a fixed study effect (DESeq (study), orange lines). The dotted black line
represents the diagonal.
a criterion to assess the “value added” for the p-value combination methods with respect to the
global analysis, and vice versa: the proportion of true positives among those uniquely identified by
a given method (e.g., the Fisher approach) as compared to another (e.g., the global analysis).
3.2.3 Results
The different methods were first compared with ROC curves, presented in Figure 3 for low and
high inter-study variability (results for zero and moderate inter-study variability are shown in
Supplementary Figure 5). We note that for clarity, the inverse normal method is not represented
on these plots as its performance was found to be equivalent to the Fisher method. It can first be
noted that for no or small inter-study variability (σ = 0 or σ = 0.15), no practical difference may
be observed among the methods. On the other hand, for moderate to large inter-study variability
(σ = 0.3 or σ = 0.5) differences among the methods become more apparent; this pattern is observed
for any number of studies. As expected, including a study effect in the global analysis improves the
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performance over a naive global analysis without such an effect. We note that the two proposed
meta-analysis methods (inverse normal and Fisher p-value combination) were found to perform
very similarly and were able, in the case of large inter-study variability, to outperform the global
analysis in terms of AUC (Supplementary Figure 1). In particular, in the presence of large inter-
study variability, the naive global analysis without a study effect unsurprisingly has the lowest
AUC, and the two meta-analysis methods yield a larger AUC than the global analysis with a study
effect.
Considering the sensitivity (Figure 4 and Supplementary Figure 6), the meta-analyses appear
to lead to similar, and in some settings considerably higher, detection power compared to the other
methods. We note that in all settings, using the intersection of independent analyses leads to much
lower sensitivity, even for low or zero inter-study variability. As for the AUC, the sensitivity was
found to be considerably improved for the global analysis when including a study effect in the GLM
model, particularly for medium to large inter-study variability. The two meta-analysis methods
were found to lead to significant improvements in sensitivity as compared to the global analysis in
the presence of moderate to large inter-study variability when three or more studies were considered.
However, for the setting that most resembles our real data analysis (2 studies, σ = 0.50), the global
analysis with study effect and meta-analyses appear to have similar detection power. Finally, we
also note that for all methods the FDR was well controlled below 5% (Supplementary Figure 2).
Based on these criteria, the two proposed meta-analysis methods (inverse normal and Fisher)
seem to perform very similarly. In order to more thoroughly investigate the differences between
p-value combination methods and the global analysis including a study effect, we calculated the
proportion of true positives uniquely detected by the Fisher method as compared to the global
analysis with study effect, and vice versa (Figure 5 and Supplementary Figure 7). In the setting
closest to the real data analysis presented above (two studies and large inter-study variability), the
proportion of true positives found uniquely by either the Fisher approach or the global analysis
with fixed study effect are very large (around 80% for both methods). This seems to suggest that
the additional genes uniquely found either by the global analysis or Fisher p-value combination
method in the real data application may indeed be of great biological interest. For more than
two studies, however, as the inter-study variability increases the proportion of truly differentially
expressed genes uniquely found by the Fisher method increases compared to the global analysis.
For example, for three studies with large inter-study variability (σ = 0.5), the proportion of truly
DE genes uniquely found with the Fisher method was equal to more than 80%, whereas it was only
around 40% for the global analysis with a study effect.
4 Conclusions
The aim of this paper was to present and compare different strategies for the differential meta-
analysis of RNA-seq data arising from multiple, related studies. As expected, naive analyses such as
the overlap of lists of differentially expressed genes found by individual studies or a global analysis
not accounting for a study effect perform very poorly. On the other hand, the two proposed
meta-analysis methods seem to have very similar performances. For low inter-study variability, the
results are very close to those of a global GLM analysis including a study effect. When the inter-
study variability increases, however, the gains in performance in terms of AUC, sensitivity, and
proportion of true positives among uniquely identified genes for the meta-analysis techniques are
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Figure 4: Sensitivity, for the simulation settings corresponding to σ = 0.15 and σ = 0.50.
Each barplot represents the results of a particular setting, with columns corresponding (from
left to right) to simulations including 2 studies, 3 studies, and 5 studies, and rows corre-
sponding (from top to bottom) to simulations with inter-study variability set to σ = 0.15
and σ = 0.50 (no inter-study variability to moderate inter-study variability). Within each
barplot, from left to right: Individual per-study analyses (green bars), Inverse Normal (pur-
ple bars), Fisher (red bars), DESeq with no study effect (blue bars), and DESeq with a fixed
study effect (orange bars).
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Figure 5: Proportion of true positives among unique discoveries for DESeq with a fixed study
effect (orange bars) and Fisher (red bars) for the simulation settings not demonstrated in
the main paper. Each barplot represents the results of a particular setting, with columns
corresponding (from left to right) to simulations including 2 studies, 3 studies, and 5 studies,
and rows corresponding (from top to bottom) to simulations with inter-study variability set
to σ = 0.15 and σ = 0.50 (no inter-study variability to moderate inter-study variability).
Error bars represent one standard deviation, and numbers in parentheses represent the mean
total number of unique discoveries for DESeq with study effect as compared to Fisher and
vice versa, respectively.
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significant as compared to the global analysis, particularly for the analysis of data from more than
two studies. We note that both of the proposed p-value combination methods are implemented in
an R package called metaRNASeq, available on the R-Forge.
Our focus in this work is on differential analyses between two experimental conditions, but
can readily be extended to multi-group comparisons. However, as previously noted, the methods
presented here are intended for the analysis of data in which all experimental conditions under con-
sideration are included in every study, thus avoiding problems due to the confounding of condition
and study effects. As with all meta-analyses, the p-value combination techniques presented here
must overcome differences in experimental objectives, design, and populations of interest, as well
as differences in sequencing technology, library preparation, and laboratory-specific effects.
The differential meta-analyses presented here concern expression studies based on RNA-seq
data. However, other genomic data are generated by high-throughput sequencing techniques, in-
cluding chromatin immunoprecipitation sequencing (CHIP-seq) and DNA methylation sequencing
(methyl-seq), and the proposed techniques could potentially be extended to these other kinds of
data. However, in order to be biologically relevant, the p-value combination methods rely on the
fact that the same test statistics, or in the case of RNA-seq data conditioned tests, are used to
obtain p-values for each study. An important challenge for the future will be to propose methods
able to jointly analyze related heterogeneous data, such as microarray and RNA-seq data, or other
kinds of genomic data. This is not straightforward in a meta-analysis framework and remains an
open research question.
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